Impact of Killip classification on acute myocardial infarction: data from the SAIKUMA registry
Authors:
- 5 July 2017
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 32 (12) , 1439-1447
Abstract
Therapeutic devices for acute myocardial infarction (AMI) have evolved dramatically in recent years. However, the impact of the Killip classification of AMI outcomes in patients undergoing aggressive percutaneous coronary intervention remains unclear. We performed a 10-year retrospective review of 2062 patients diagnosed with AMI, and divided the data into two 5-year intervals: 2005–2009 (n = 1071), and 2010–2014 (n = 991). No difference was observed in in-hospital mortality rate between the two periods (first period, 11.5% vs second period, 9.7%; P = 0.19). The incidence of stent thrombosis was not significantly different between the two periods, and very few thrombi occurred in patients who received second-generation drug-eluting stents (DES) (0.98%: 5/511). In-hospital mortality due to stent thrombosis was high in the full cohort (15%). During the second period, in-hospital mortality was lower in Killip class 4 patients, although the difference was not significant (59.1 vs 47.5%, P = 0.07). Multivariable logistic regression identified several factors that significantly affected in-hospital mortality, including age [odds ratio (OR) 1.07], left main trunk (OR 2.47), peak CPK value above 5000 IU/L (OR 3.18), and Killip class 4 (OR 15.63). We evaluated trends in in-hospital mortality among patients with AMI over a 10-year period. New DES and the frequent use of mechanical support in patients with hemodynamic compromise tended to improve in-hospital mortality, but the effect was not significant. Notably, Killip class 4 on admission was associated with an estimated 16-fold increased risk of in-hospital death.Keywords
This publication has 26 references indexed in Scilit:
- Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohortHeart and Vessels, 2016
- Inter-Facility Transfer vs. Direct Admission of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionCirculation Journal, 2016
- The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-upHeart and Vessels, 2015
- Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trialThe Lancet, 2013
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsNew England Journal of Medicine, 2010
- Seasonal Pattern of Incidence and Case Fatality of Acute Myocardial Infarction in a Japanese Population (from the Takashima AMI Registry, 1988 to 2003)The American Journal of Cardiology, 2008
- Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionJACC, 2005
- Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary AngioplastyCirculation, 2004
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967